Level C· Early human research exploring benefitsCase Report / SeriesPubMed

Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report.

Lendeckel S., Jödicke A., Christophis P., Heidinger K., Wolff J., Fraser JK.

Case Report / Series on Chronic Wound, published in J Craniomaxillofac Surg (2004) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
J Craniomaxillofac Surg (2004)
Country
Scotland
Reported sample size
—
Source database
PubMed
PMID
15555520
DOI
10.1016/j.jcms.2004.06.002
Citations
411

Abstract (original English)

This is a report of a 7-year-old girl suffering from widespread calvarial defects after severe head injury with multifragment calvarial fractures, decompressive craniectomy for refractory intracranial hypertension and replantation of cryopreserved skull fragments. Chronic infection resulted in an unstable skull with marked bony defects. Two years after the initial injury the calvarial defects were repaired. Due to the limited amount of autologous cancellous bone available from the iliac crest, autologous adipose derived stem cells were processed simultaneously and applied to the calvarial defects in a single operative procedure. The stem cells were kept in place using autologous fibrin glue. Mechanical fixation was achieved by two large, resorbable macroporous sheets acting as a soft tissue barrier at the same time. The postoperative course was uneventful and CT-scans showed new bone formation and near complete calvarial continuity three months after the reconstruction.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Absorbable ImplantsAdipocytesBone RegenerationBone TransplantationChildFemaleFibrin Tissue AdhesiveFollow-Up StudiesFracture FixationFractures, Closed

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research